Related Experiment Video

Updated: Jul 21, 2026

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis
06:27

Use of a Monocyte Monolayer Assay to Evaluate Fcγ Receptor-mediated Phagocytosis

Published on: January 2, 2017

Binding of alpha 2HS glycoprotein in peripheral blood monocytes

J G Lewis, C M André

    Immunological Communications
    |January 1, 1981
    PubMed

    Keywords:
    alpha 2HS glycoprotein bindingmonocyte interactionphagocytic enhancementcell surface binding

    More Related Videos

    Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis09:12

    Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis

    Published on: October 17, 2018

    Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay11:27

    Prediction of Red Blood Cell Antibody Significance Using the Monocyte-Macrophage Assay

    Published on: February 7, 2025

    Related Concept Videos

    Blood Transfusion and Agglutination02:45

    Blood Transfusion and Agglutination

    Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
    History
    The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
    Drug Binding to Blood Components01:30

    Drug Binding to Blood Components

    When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
    HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...